A multi-center clinical study of integrated Traditional Chinese and Western medicine in the management of atherosclerotic cardiovascular disease

Phase 4

• Conditions: arteriosclerotic cardiovascular disease

• Registration Number: ITMCTR2000003930
• Lead Sponsor: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Aged 20 to 85 years, voluntarily participate in the study and sign the informed consent;
2) patients with coronary lesion stenosis >= 20% but < 70%, Blood fractional flow eserve (FFR)>
0.80, without vascular reconstruction.

Exclusion Criteria

1) Pregnant and nursing women;
2) ALT or AST >=2 ULN;
3) severe renal insufficiency (Cr > 177umol/L);
4) hemoglobin < 90g/L or platelet < 100x10^9/L or leukocyte < 3.0x10^9/L;
5) acute myocardial infarction, stroke, acute coronary syndrome, and coronary artery PCI in the last 3 months;
6) Participated in other clinical trials within the past 1 month;
7) Screening subjects with a history of malignant tumor in the previous 5 years;
8) Mental diseases;
9) Life expectancy is shorter than the duration of the experiment;
10) Not suitable for participants.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Minimum lumen area of the coronary artery;

Secondary Outcome Measures

Name	Time	Method
Blood fractional flow eserve;